Table 1 Basic clinical data and univariate analysis of overweight ATAAD patients
Variable | The overall | No-AHD | AHD | P |
|---|---|---|---|---|
Gender (male/female) | 109/38 | 84/34 | 25/4 | 0.098 |
Age | 51.04 ± 10.17 | 51.47 ± 10.45 | 49.28 ± 8.85 | 0.299 |
Weight(Kg) | 75(69,83) | 73.5(69,81.25) | 76(70,85) | 0.201 |
Height(cm) | 166.7 ± 8.34 | 166.91 ± 8.63 | 165.93 ± 7.10 | 0.574 |
Hypertension (yes/no) | 110/37 | 89/29 | 21/8 | 0.738 |
Smoking history (yes/no) | 79/68 | 60/58 | 19/10 | 0.156 |
Diabetes (yes/no) | 11/136 | 9/109 | 2/27 | 0.893 |
WBC | 11.92 ± 3.64 | 11.81 ± 3.66 | 12.39 ± 3.59 | 0.442 |
Neutrophile granulocyte | 9.77 ± 3.47 | 9.66 ± 3.460 | 10.21 ± 3.53 | 0.449 |
Lymphocyte | 1.18(0.83,1.62) | 1.19(0.83,1.56) | 1.16(0.74,1.67) | 0.963 |
Neutrophil/lymphocyte ratio | 7.6(5.43,13.65) | 7.52(5.36,13.29) | 7.6(5.66,15.03) | 0.653 |
HCT | 0.41(0.38,0.44) | 0.41(0.38,0.44) | 0.427(0.39,0.44) | 0.174 |
PLT | 175(141,218) | 175(143,218) | 176(139,210) | 0.848 |
APTT | 37.1(33.7,38.9) | 37(33.55,38.96) | 37.1(34.15,38.7) | 0.586 |
PT | 13.75 ± 0.93 | 13.76 ± 0.91 | 13.71 ± 1.05 | 0.811 |
INR | 1.05(1,1.13) | 1.05(1,1.13) | 1.05(1,1.125) | 0.779 |
FIB | 2.95(2.22,3.83) | 2.94(2.22,3.83) | 2.97(2.14,4) | 0.697 |
FDP | 29.9(11.82,54.34) | 26.51(9.48,54.71) | 34.2(14.71,53.43) | 0.607 |
DD2 | 9.74(4.57,17.43) | 9.5(4.43,17.31) | 10.85(6.61,17.95) | 0.519 |
LVEF | 0.63(0.59,0.68) | 0.63(0.59,0.68) | 0.66(0.61,0.69) | 0.264 |
AST | 23(17,36) | 22(16,35.25) | 27(19,57.5) | 0.054 |
ALT | 23(17,46) | 22.4(16.4,43.75) | 39(20.8,46.5) | 0.042 |
TBIL | 14.7(11.5,21.3) | 14.4(10.8,20.18) | 17.2(12.2,24.3) | 0.171 |
UBIL | 8.9(6.8,13.2) | 8.9(6.7,13.05) | 9.3(7.55,15.7) | 0.351 |
Albumin | 38.5(35.2,40.6) | 38.65(35.18,40.83) | 37.7(35.6,39.3) | 0.553 |
Cr | 84(64,105) | 81(61,95.5) | 113(83,138.5) | <0.001 |
BUN | 6.1(4.8,8.3) | 5.65(4.5,7.85) | 7.1(6,8.35) | 0.008 |
K | 3.8(3.6,4.1) | 3.8(3.6,4.1) | 3.9(3.75,4.25) | 0.139 |
Na | 139(137,140) | 139(138,140) | 138(137,140) | 0.169 |
Cl | 107(105,109) | 107(105,109.25) | 106(104,108.5) | 0.061 |
Ca | 2.14 ± 0.12 | 2.14 ± 0.12 | 2.13 ± 0.13 | 0.793 |
CKMB | 1.5(0.6,3.9) | 1.4(0.6,4) | 1.7(0.85,3.15) | 0.472 |
aTn1 | 0.015(0.004,0.108) | 0.0135(0.004,0.0995) | 0.022(0.007,0.245) | 0.189 |
MYO | 54.25(33.78,124.3) | 53.5(31.2,118.88) | 60.65(43.15,167.83) | 0.181 |
Intraoperative infusion of RBCs | 800(400,800) | 800(400,800) | 800(750,800) | 0.468 |
Infusion of plasma | 600(600,600) | 600(600,600) | 600(600,600) | 0.575 |
Platelet transfusions | 150(150,300) | 150(150,300) | 150(150,300) | 0.391 |
Operation (Sun’s/Bentall) | 127/20 | 99/19 | 28/1 | 0.139 |
Turnaround time | 147(129,170) | 146.5(129,169.5) | 147(129,170.5) | 0.961 |
Deep hypothermia time | 13(12,15) | 13(12,15) | 13(12,13.5) | 0.054 |
Aortic cross-clamping time | 87(75,97) | 86.5(74.75,96) | 89(79,101.5) | 0.415 |
Lowest rectal temperature | 27.8(26.8,28.6) | 27.9(26.8,28.7) | 27.6(26.95,28.4) | 0.512 |
Minimum nasal temperature | 23.92 ± 1.42 | 23.89 ± 1.35 | 24.00 ± 1.70 | 0.712 |